Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets... Show more
TECH saw its Momentum Indicator move above the 0 level on November 20, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for TECH just turned positive on November 24, 2025. Looking at past instances where TECH's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
TECH moved above its 50-day moving average on November 20, 2025 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for TECH moved above the 200-day moving average on October 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TECH advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 226 cases where TECH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for TECH moved out of overbought territory on November 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TECH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
TECH broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TECH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.112) is normal, around the industry mean (27.168). P/E Ratio (131.653) is within average values for comparable stocks, (52.496). Projected Growth (PEG Ratio) (0.890) is also within normal values, averaging (1.897). Dividend Yield (0.005) settles around the average of (0.048) among similar stocks. P/S Ratio (8.403) is also within normal values, averaging (334.447).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TECH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
a biological products manufacturer
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ASA | 52.72 | 1.80 | +3.53% |
| ASA Gold AND Precious Metals Limited | |||
| HOOW | 59.98 | 0.30 | +0.50% |
| Roundhill HOOD WeeklyPay ETF | |||
| AAVM | 29.52 | 0.12 | +0.39% |
| Alpha Architect Global Factor Equity ETF | |||
| ECON | 27.18 | 0.09 | +0.33% |
| Columbia Res Enh Emerging Econ ETF | |||
| NXN | 12.15 | 0.02 | +0.12% |
| Nuveen NY SEL Tax-Free | |||
A.I.dvisor indicates that over the last year, TECH has been loosely correlated with AXON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To TECH | 1D Price Change % | ||
|---|---|---|---|---|
| TECH | 100% | -0.19% | ||
| AXON - TECH | 61% Loosely correlated | +1.31% | ||
| MRVI - TECH | 45% Loosely correlated | -0.55% | ||
| MRNA - TECH | 44% Loosely correlated | +3.88% | ||
| ARRY - TECH | 44% Loosely correlated | +0.27% | ||
| FTRE - TECH | 44% Loosely correlated | +0.63% | ||
More | ||||